MacroGenics | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.86B 306M 2024-12
Amgen USD 1.88B 253M 2024-12
AstraZeneca USD 5.55B 307M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Daiichi Sankyo JPY 185.63B 23.39B 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Genmab DKK 1.25B 384M 2024-12
Geron USD 43.37M 7.49M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
J&J USD 6.45B 975M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.85B 148M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Xencor USD 14.92M 148K 2024-12



MacroGenics Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Apr 2025.